dm+d
359380005
Medicine Compliance Aid Stability
Regurin XL
Mylan
Mylan
Regurin XL
Capsules m/r 60mg
A2 · Amber 2 No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special precautions for storage
23 November 2022
Regurin
Mylan
Mylan
Regurin
Tablets f/c 20mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in airtight container. Protect from light
23 November 2022
Lactation Safety Information
Oxybutynin
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties although long half-life increases risk of accumulation in breastfed infants
Monitor infant for anticholinergic effects, e.g. urinary retention, colic and constipation
10 August 2020